Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 357 shares at $13.43 ($5K) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $5k TARS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |